Table 2.
Carotid Artery Intima-Media Thickness (CIMT) Progression by Treatment Group
B-Vitamins (n=248) | Placebo (n=242) | p-value* | |
---|---|---|---|
All subjects, adjusted for baseline CIMT strata (<≥0.75 mm) | 0.0022 (0.0005)† | 0.0029 (0.0007) | 0.31 |
Baseline fasting plasma total homocysteine | |||
<9.1 μmol/L (n=126/119)‡ | 0.0028 (0.0006) | 0.0021 (0.0007) | 0.41 |
≥9.1 μmol/L (n=122/123) | 0.0016 (0.0007) | 0.0038 (0.0007) | 0.02 |
p-values from mixed effects models
Mean (SE) carotid artery intima-media thickness (CIMT) progression rate (mm/year)
Sample sizes in sub-group analysis (B-vitamins/Placebo)